At the news
? NEUTRALIMPACT 3/10 144 filed Apr 8, 2026 at 16:35 ET
Berndt Modig, a director and officer of Pharvaris N.V., filed a Form 144 to notify of intent to sell up to 23,333 common shares acquired through vested restricted stock units. The sale is planned on the NASDAQ exchange, with proceeds to be handled through Morgan Stanley Smith Barney.
- Reporting person: Berndt B.A.E. Modig, Director and Officer of Pharvaris N.V.
- Number of shares proposed for sale: 23,333 common shares
- Shares were acquired upon vesting of restricted stock units between 05/31/2025 and 03/12/2026
- Filing date: April 8, 2026
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access